SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : NovaCare Employee Services (NASDAQ:NCES)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Apakhabar who wrote (165)9/8/1998 4:37:00 PM
From: Todd D. Wiener  Read Replies (5) of 376
 
I think that even $20 for THQI would be very disappointing, considering I expected a year-end price of $35, only a few months ago. At some point, the stock will catch up to its deserved valuation. It just may happen later than sooner. But until THQI can give a clear indication of the 1999 lineup of titles, the market will remain concerned about earnings growth.

As far as NCES goes, I believe the short interest is negligible. In fact most interest in NCES is negligible, which is why it's trading down. I recommend aggressive accumulation of the stock at current levels. It's trading at about 10 times next year's cash flow. This is arguably cheaper than THQI, considering the less risky business of NCES. NCES should be able to achieve long-term growth of at least 35%, so the current valuation is an aberration.

Todd
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News